InterventionsReview
The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact
Journal of Immunotherapy and Precision Oncology
The paper
Joud Hajjar, Bettzy Stephen, Ashley Aaroe, Aung Naing
Show 46 more authors
Mazen M. Aiche, Nagham Al‐Zubidi, May Ameri, Kaitlyn A. Brooks, Ivan Darin Carabenciov, Mark Steven Chambers, Amina Lateef Chaudhry, Jean M. Connors, Michael A. Davies, Kala Chand Debnath, Saadia A. Faiz, Clifton David Fuller, Ryan P. Goepfert, Dan S. Gombos, Shruti Gupta, Matthew James Hadfield, Katherine A. Hutcheson, Shajedul Islam, Abdullah Nabeel Jalal, Migara Jayasekera, Khalid Jazieh, Aye Khine, Peter Y. Kim, Stephen Yenzen Lai, Yu Leo Lei, Yuanteng Jeff Li, Svetomir N. Markovic, Holly McMillan, Amy Catherine Moreno, Fiorinda F. Muhaj, Marc‐Elie Nader, Adegbenga O. Otun, Omar Pacha, Nicolas L. Palaskas, Anisha B. Patel, Nimisha Patel, Zoe Quandt, Oded Sagiv, Elad Sharon, Malek Shatila, Ajay Sheshadri, Maria Eugenia Suarez-Almazor, Anusha Shirwaikar Thomas, Yinghong Wang, Alex Won, Hao Zhang,Baylor College of Medicine · The University of Texas MD Anderson Cancer Center
Journal of Immunotherapy and Precision Oncology · 29 Sep 2026
